Cannabis Stock CRLBF Gains 25% in a Month: Time to Buy, Sell or Hold?
CRLBF surges 25% this month on reform hopes, but revenue declines, margin pressure and stiff competition cloud its outlook.
HITI: Initiating Coverage of a High-Growth Specialty Retailer Focused on Cannabis with Sustainable Competitive Advantages
HITI READ THE FULL HITI RESEARCH REPORT We are initiating coverage of High Tide Inc. (NASDAQ:HITI) with a 12-month price target of $6.00, translating into sizeable upside potential from the stock’s …
Insider buying points to opportunity in Canadian cannabis stocks
These are challenging times for the Canadian economy, but the Canadian stock market is a bright spot. The INK Canadian Insider Index advanced 16.4 per cent in the first eight months of the year, …
Cannabis Stock CRON Trades Near 52-Week High: How to Play
One of the leading Canadian cannabis producers, Cronos Group’s CRON stock hit $2.50 apiece on Thursday, close to its 52-week high of $2.77. This growth in share price was primarily driven by hopes of …
MSOS: Cannabis Investors Betting Big On Trump
Cannabis stocks surge as rescheduling optimism grows. Learn how MSOS ETF drove gains and what future moves could mean for investors.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Ascend Wellness No Longer Stands Out Among Cannabis Stocks
AAWH’s business fundamentals remain challenged, with declining sales, shrinking margins, rising debt, and a deteriorating balance sheet. Learn more about AAWH stock here.
Hemp THC ban, cannabis reform in limbo during federal shutdown
President Donald Trump could still reschedule marijuana at any time even as the fate of hemp-derived THC hangs in the balance.
This Stock Has Doubled in the Past 6 Months: Is It Too Late to Buy?
That’s still a meaningful amount. All these challenges have weighed on Tilray and its peers in the industry. Tilray has generated inconsistent (at best) financial results due to these and other …
Are Cannabis Stocks Ready for a Long-Term Rebound?
Cannabis stocks are soaring today in light of some positive remarks from President Donald Trump. What implications could this have for the industry’s long-term prospects?
Tilray Brands (TLRY) Stock Is Surging Monday: What’s Going On?
Shares of Tilray Brands are trading sharply higher Monday morning. The stock is being bolstered by a positive note from Jefferies and growing optimism around significant U.S. cannabis reform this year …
Tilray’s High Hopes: The Catalyst Driving Cannabis Stocks
A fairly consistent climb in Tilray Brands’ (NASDAQ: TLRY) stock price has started to capture the market’s attention. After touching a 52-week low of 35 cents, the stock has rallied dramatically, …
5 sectors that have been soaring lately as the stock market has struggled
Stocks in areas like airlines, lithium, solar, and homebuilding are being propelled by some bullish near-term catalysts, Ned Davis Research said.
If You’d Invested $1,000 in Tilray Stock 5 Years Ago, Here’s How Much You’d Have Today
So, if you had invested $1,000 in Tilray five years ago, you’d have about $163 left as of this writing. By comparison, $1,000 invested in the S&P 500 five years ago would be worth $2,067 today.
Curaleaf, Green Thumb, and IIPR: The 3 Cannabis Stocks Lighting Up the Market
The cannabis industry today presents a blend of opportunity and risk—growth is fueled by ongoing state-level legalization, while federal …
Recent Comments